Urokinase-type plasminogen activator (uPA) is initially produced by cells as a single-chain precursor (pro-uPA), which can be cleaved by the serine protease plasmin to form the two-chain molecule uPA. This latter protease efficiently converts the inactive zymogen plasminogen into plasmin. Cell surface binding of both pro-uPA and plasminogen is known to enhance the rate of plasminogen activation. It has been postulated that this may be due, in part, to an enhanced plasmin-mediated feedback activation of pro-uPA. This study directly demonstrates the enhancement by cells of this feedback activation loop by showing that uPA is generated more rapidly from pro-uPA and plasminogen in the presence of human promonocytic U937 cells than it is under fluid-phase conditions. Moreover, the enhanced activation of pro-uPA and plasminogen observed in the presence of cells was significantly less susceptible to inhibition by alpha 2-antiplasmin. Finally, the presence of cells not only potentiated the production of plasmin, as measured using a plasmin-specific peptide substrate, it also potentiated the cleavage of a natural protein substrate, 125I-labeled recombinant interferon-gamma, even in the presence of alpha 2-antiplasmin or alpha 2-macroglobulin. These results demonstrate that cell-associated plasmin mediates a positive feedback amplification of plasminogen activation and thereby potentiates the proteolysis of natural plasmin substrates, even in the presence of plasma protease inhibitors.
No takes yet. Share an insight, caveat, or question.
Duval-Jobe et al. (1994) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: